The University of Chicago Header Logo

Connection

Rudolph Navari to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Rudolph Navari has written about Cost-Benefit Analysis.
Rudolph Navari
Connection Strength
0.160
Cost-Benefit Analysis
  1. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients. Support Care Cancer. 2021 Aug; 29(8):4269-4275.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.